Journal of Kerman University of Medical Sciences

Current Issue

By Issue

By Author

Author Index

Keyword Index

About Journal

Aims and Scope

JKMU Ethical Policies

Indexing and Abstracting

Related Links

FAQ

Peer Review Process

News

Metric

Editorial Policies

Data Sharing Policy

Lamotrigine-Related Skin Side Effects Were Associated with some HLA-B Alleles in Iranian Epileptic Patients

Document Type : Original Article

Authors

1 Neurology Research Center, Kerman University of Medical Science, Kerman, Iran

2 Department of Genetics, Kerman University of Medical Science, Kerman, Iran

3 Department of Immunology, Medical School, Kerman University of Medical Sciences, Kerman, Iran

4 Department of Immunology, Medical School, Kerman University of Medical Sciences, Kerman, Iran & Molecular Medicine Research Center, Research Institute of Basic Medical Sciences, Rafsanjan University of Medical Sciences, Rafsanjan, Iran

Abstract

Background: Recent evidences revealed that some genetic factors strongly predict occurrence of lamotrigine (LTG)-related skin reactions. The present study aimed to assess the association between some human leukocyte antigen (HLA)-B alleles and risk of LTG-related skin reactions among a sample of epileptic patients.
Methods: Totally, 36 epileptic patients expressing LTG-related skin reactions and 70 sex- and age-matched healthy individuals were enrolled into this case-control study. Blood samples were collected from all participants and genomic DNA was extracted by salting-out method. HLA-B alleles were determined using standard sequence specific primer-PCR (SSP-PCR) technique.
Results: Of the 31 HLA alleles assessed in our survey, the frequencies of HLA-B*38 and HLA-B*40 were significantly higher in epileptic patients with LTG-related skin reactions when compared to the control group. In term of gender, the frequency of HLA-B*40 allele was significantly higher in the epileptic men with LTG-related skin reactions, whereas the frequency of HLA-B*38 allele was significantly higher in the epileptic women with LTG-related skin reactions than controls with the same gender. Moreover, the frequency of HLA-B*38 allele in patients with high grade of LTG-related skin side effects was significantly higher than patients with low grade of LTG-related skin side effects.
Conclusion: These results indicated possible association between HLA-B*40 and HLA-B*38 alleles and LTG-induced skin lesions in Iranian epileptic patients. HLA-B*40 and HLA-B*38 alleles might be differentially expressed in male and female epileptic patients with LTG-induced skin lesions.

Keywords

References
  1. Ebrahimi HA. Challenges in the Treatment of Epilepsy. Journal of Kerman University of Medical Sciences, 2012; 19(2): 212-224.
  2. Ebrahimi HA, Iranmanesh F, Ansari M, Molla-Mohammadi H, Ebrahimi S. Evaluation of L-arginine Effects on Refractory Seizures in Epileptic Patients. Journal of Kerman University of Medical Sciences, 2020; 27 (3): 213-221
  3. Ebrahimi H, Shafa M, Hakimzadeh Asl S. Prevalence of active epilepsy in Kerman, Iran: a house based survey. Acta Neurol Taiwan. 2012; 21(3):115-24. PMID: 23196731.
  4. Ebrahimi HA, Ebrahimi F. The effect of lamotrigine on epilepsy. Iran J Neurol. 2012; 11(4):162-3.
  5. Reid JG, Gitlin MJ, Altshuler LL. Lamotrigine in psychiatric disorders. J Clin Psychiatry. 2013; 74(7):675-84. doi: 10.4088/JCP.12r08046.
  6. Kim YJ, Ko HH, Han ES, Lee CS. Lamotrigine inhibition of rotenone- or 1-methyl-4-phenylpyridinium-induced mitochondrial damage and cell death. Brain Res Bull. 2007; 71(6):633-40. doi: 10. 1016/j.brainresbull.2006.12.006.
  7. Stefani A, Spadoni F, Siniscalchi A, Bernardi G. Lamotrigine inhibits Ca2+ currents in cortical neurons: functional implications. Eur J Pharmacol. 1996; 307(1):113-6. doi: 10.1016/0014-2999(96)00265-8. 
  8. Brigo F, Igwe SC. Ethosuximide, sodium valproate or lamotrigine for absence seizures in children and adolescents. Cochrane Database Syst Rev. 2017; 2(2):CD003032. doi: 10.1002/14651858.CD003032.pub3. 
  9. Gilman JT. Lamotrigine: an antiepileptic agent for the treatment of partial seizures. Ann 1995; 29(2):144-51. doi: 10.1177/106002809502900209. 
  10. Tatum WO, French JA. Lamotrigine and side effects: another headache. Neurology. 2012; 78(12):849-50. doi: 10.1212/WNL.0b013e31824d186e. 
  11. Yasam VR, Jakki SL, Senthil V, Eswaramoorthy M, Shanmuganathan S, Arjunan K, et al. A pharmacological overview of lamotrigine for the treatment of epilepsy. Expert Rev Clin Pharmacol. 2016; 9(12):1533-1546. doi: 10.1080/17512433.2016.1254041. 
  12. Wang XQ, Xiong J, Xu WH, Yu SY, Huang XS, Zhang JT, et al. Risk of a lamotrigine-related skin rash: current meta-analysis and postmarketing cohort analysis. Seizure. 2015; 25:52-61. doi: 10.1016/j.seizure.2014.12.001. 
  13. Wang XQ, Lv B, Wang HF, Zhang X, Yu SY, Huang XS, et al. Lamotrigine induced DIHS/DRESS: Manifestations, treatment, and outcome in 57 patients. Clin Neurol Neurosurg. 2015; 138:1-7. doi: 10.1016/j.clineuro.2015.07. 008. 
  14. Chang LR, Chang HC, Lin YH. Quetiapine and valproate-associated neutropenia and thrombocytopenia after lamotrigine-induced Steven-Johnson syndrome. J Clin Psychopharmacol. 2012; 32(1):133-4. doi: 10.1097/JCP.0b013e31823f87e5. 
  15. Normann C, Hummel B, Schärer LO, Hörn M, Grunze H, Walden J. Lamotrigine as adjunct to paroxetine in acute depression: a placebo-controlled, double-blind study. J Clin Psychiatry. 2002; 63(4):337-44. doi: 10.4088/jcp.v63n0411.
  16. Kamaliah MD, Zainal D, Mokhtar N, Nazmi N. Erythema multiforme, Stevens-Johnson syndrome and toxic epidermal necrolysis in northeastern Malaysia. Int J Dermatol. 1998; 37(7):520-3. doi: 10.1046/j.1365-4362.1998.00490.x. 
  17. Negrini S, Becquemont L. HLA-associated drug hypersensitivity and the prediction of adverse drug reactions. Pharmacogenomics. 2017; 18(15):1441-1457. doi: 10.2217/pgs-2017-0090.
  18. Jafarzadeh A, Bagheri-Jamebozorgi M, Nemati M, Golsaz-Shirazi F, Shokri F. Human leukocyte antigens influence the antibody response to hepatitis B vaccine. Iran J Allergy Asthma Immunol. 2015; 14(3):233-45. PMID: 26546891.
  19. Jafarzadeh A, Shokri F. TH1 and TH2 responses are influenced by HLA antigens in healthy neonates vaccinated with recombinant hepatitis B vaccine. Iran J Allergy Asthma 2012; 11(4):308-15. PMID: 23264407.
  20. Illing PT, Purcell AW, McCluskey J. The role of HLA genes in pharmacogenomics: unravelling HLA associated adverse drug reactions. Immunogenetics. 2017; 69(8-9):617-630. doi: 10.1007/s00251-017-1007-5. 
  21. Pichler WJ, Adam J, Watkins S, Wuillemin N, Yun J, Yerly D. Drug Hypersensitivity: How Drugs Stimulate T Cells via Pharmacological Interaction with Immune Receptors. Int Arch Allergy Immunol. 2015; 168(1):13-24. doi: 10.1159/000441280. 
  22. Kim BK, Jung JW, Kim TB, Chang YS, Park HS, Moon J, et al. HLA-A*31:01 and lamotrigine-induced severe cutaneous adverse drug reactions in a Korean population. Ann Allergy Asthma Immunol. 2017;118(5):629-630. doi: 10.1016/j.anai.2017.02.011.
  23. Ito A, Shimada H, Ishikawa K, Takeo N, Hatano Y, Katagiri K, et al. Association between HLA-DRB1*0405, -DQB1*0401 and -DQA1*0303 alleles and lamotrigine-induced cutaneous adverse drug reactions. A pilot case-control study from Japan. J Affect Disord. 2015; 179:47-50. doi: 10.1016/j.jad.2015.03.018. 
  24. Fricke-Galindo I, Martinez-Juarez IE, Monroy-Jaramillo N, Jung-Cook H, Falfan-Valencia R, Ortega-Vazquez A, et al. HLA-A*02:01: 01/-B*35:01:01/-C*04:01:01 haplotype associated with lamotrigine-induced maculopapular exanthema in Mexican Mestizo patients. Pharmacogenomics. 2014; 15(15):1881-91. doi: 10.2217/pgs.14.135.
  25. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 1988; 16(3):1215. doi: 10.1093/nar/16.3.1215.
  26. Messenheimer J, Mullens EL, Giorgi L, Young F. Safety review of adult clinical trial experience with lamotrigine. Drug Saf. 1998; 18(4):281-96. doi: 10.2165/00002018-199818040-00004..
  27. Lonjou C, Borot N, Sekula P, Ledger N, Thomas L, Halevy S, et al. RegiSCAR study group. A European study of HLA-B in Stevens-Johnson syndrome and toxic epidermal necrolysis related to five high-risk drugs. Pharmacogenet Genomics. 2008; 18(2):99-107. doi: 10.1097/FPC.0b013e3282f3ef9c.
  28. Winchester R, Minevich G, Steshenko V, Kirby B, Kane D, Greenberg DA, et al. HLA associations reveal genetic heterogeneity in psoriatic arthritis and in the psoriasis phenotype. Arthritis Rheum. 2012; 64(4):1134-44. doi: 10.1002/art.33415.
  29. Loewenthal R, Slomov Y, Gonzalez-Escribano MF, Goldberg I, Korostishevsky M, Brenner S, et al. Common ancestral origin of pemphigus vulgaris in Jews and Spaniards: a study using microsatellite markers. Tissue Antigens. 2004; 63(4):326-34. doi: 10.1111/j.0001-2815.2004. 00191.x.
  30. Moon J, Kim TJ, Lim JA, Sunwoo JS, Byun JI, Lee ST, et al. HLA-B*40:02 and DRB1*04:03 are risk factors for oxcarbazepine-induced maculopapular eruption. Epilepsia. 2016; 57(11):1879-1886. doi: 10.1111/epi.13566.
  31. Hsiao YH, Hui RC, Wu T, Chang WC, Hsih MS, Yang CH, et al. Genotype-phenotype association between HLA and carbamazepine-induced hypersensitivity reactions: strength and clinical correlations. J Dermatol Sci. 2014; 73(2):101-9. doi: 10.1016/j.jdermsci.2013.10.003.
  32. Cheung YK, Cheng SH, Chan EJ, Lo SV, Ng MH, Kwan P. HLA-B alleles associated with severe cutaneous reactions to antiepileptic drugs in Han Chinese. Epilepsia. 2013; 54(7):1307-14. doi: 10.1111/epi.12217. 
  33. Erdogan MF, Gulec S, Tutar E, Guldal M, Baskal N, Erdogan G. HLA-B40-, HLA-Cw3-, and HLA-DR5-associated susceptibility to amiodarone-induced thyroid dysfunction. Thyroid. 2000; 10(4):369-70. doi: 10.1089/thy.2000.10.369.
  34. Chan SH, Tan T, Wee GB, Lim AY. HLA and antibiotic allergic skin eruption. Annals of the Academy of Medicine, Singapore. 1988; 17(4):518-9.
  35. Kazeem GR, Cox C, Aponte J, Messenheimer J, Brazell C, Nelsen AC, et al. High-resolution HLA genotyping and severe cutaneous adverse reactions in lamotrigine-treated patients. Pharmacogenet Genomics. 2009; 19(9):661-5. doi: 10.1097/FPC.0b013e32832c347d.
  36. Moon J, Park HK, Chu K, Sunwoo JS, Byun JI, Lim JA, et al. The HLA-A*2402/Cw*0102 haplotype is associated with lamotrigine-induced maculopapular eruption in the Korean population. Epilepsia. 2015; 56(10):161-7. doi: 10.1111/epi.13087.

 

Journal of Kerman University of Medical Sciences
Volume 29, Issue 1
January and February 2022
Pages 71-78
Files
Share
How to cite
Statistics